6 WORLD GASTROENTEROLOGY NEWS JANUARY 2015 Editorial | Expert Point of View | Gastro 2015: AGW/WGO | WDHD News | WGO & WGOF News | WGO Global Guidelines | Calendar of Events 7. Huang YT, Jen CL, Yang HI, Lee MH, Su J, Lu SN, et al. Lifetime risk and sex difference of hepato-cellular carcinoma among patients with chronic hepatitis B and C. J Clin Oncol 2011;29:3643-3650. 8. Liu CJ, Chuang WL, Lee CM, Yu ML, Lu SN, Wu SS, et al. An open label, comparative, multi-center study of peginterferon alfa- 2a plus ribavirin in the treatment of patients with chronic hepatitis C/ hepatitis B co-infection versus those with chronic hepatitis C monoinfection. Gastroenterology 2009;136:496-504. 9. Yu ML, Lee CM, Chen CL, Chuang WL, Lu SN, Liu CH, et al. Sustained HCV clearance and increased HBsAg seroclearance in patients with dual chronic hepati-tis C and B during post-treatment follow-up. Hepatology 2013 Jan 15. doi: 10.1002/hep.26266. 10. Liu CJ, Chu YT, Shau WY, Kuo RNC, Chen PJ, Lai MS. Treat-ment of patients with dual hepa-titis C and B by peginterferon alfa and ribavirin reduced risk of hepa-tocellular carcinoma and mortality. Gut 2013 May 15. Epub ahead of print 11. Raimondo G, Brunetto MR, Pontisso P, Smedile A, Maina AM, Saitta C, et al. Longitudinal evalu-ation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-co-infected patients. Hepatology 2006;43:100- 107. 12. Yeh ML, Hung CH, Huang JF, Liu CJ, Lee CM, Dai CY, et al. Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepati-tis B and C viruses. PLoS One 2011;6:e20752. 13. Liaw YF, Kao JH, Piratvisuth T, Chan HLY, Chien RN, Liu CJ, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 up-date. Hepatol Int 2012;6:531-561. 14. Liu CJ, Chen PJ. Updates in the treatment and outcomes of dual chronic hepatitis C and B Virus infection. World J Gastroenterol 2014; 20: 2955-2961. 15. Liu CJ. Treatment of patients with dual HCV and HBV infection: Resolved and unresolved issues. J Gastroenterol Hepatol 2014;29:26- 30.
ewgn-vol19-issue4-FINAL
To see the actual publication please follow the link above